Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5139]

Early phase trial of ibrutinib for chronic lymphocytic leukaemia

Dr Samantha Jaglowski - Ohio State University Medical Center, Columbus, USA

Early phase trial of ibrutinib for chronic lymphocytic leukaemia ( Dr Samantha Jaglowski - Ohio State University Medical Center, Columbus, USA )

How malignant cells in patients with CLL escape T-cell recognition

Dr Alan G Ramsay - Barts Cancer Institute, Queen Mary University of London, UK

How malignant cells in patients with CLL escape T-cell recognition ( Dr Alan G Ramsay - Barts Cancer Institute, Queen Mary University of London, UK )

Clinical trials for rare tumour types

Dr William Tap – Memorial Sloan-Kettering Cancer Center, New York, USA

Clinical trials for rare tumour types ( Dr William Tap – Memorial Sloan-Kettering Cancer Center, New York, USA )

First line treatment against metastatic breast cancer

Dr Karen Gelmon – BC Cancer Agency, Vancouver, Canada

First line treatment against metastatic breast cancer ( Dr Karen Gelmon – BC Cancer Agency, Vancouver, Canada )

Effects of lapatinib and trastuzumab on progression free survival

Dr Nancy Lin – Dana Farber Cancer Institute, Boston, MA, USA

Effects of lapatinib and trastuzumab on progression free survival ( Dr Nancy Lin – Dana Farber Cancer Institute, Boston, MA, USA )

President's overview of ASCO 2012

Dr Michael Link - Stanford School of Medicine, California, USA

President's overview of ASCO 2012 ( Dr Michael Link - Stanford School of Medicine, California, USA )

Afatinib delays progression of advanced lung adenocarcinomas

Dr James Yang - National Taiwan University Hospital, Taipei

Afatinib delays progression of advanced lung adenocarcinomas ( Dr James Yang - National Taiwan University Hospital, Taipei )

Routine molecular testing of non-small cell lung cancers in community settings

Dr Thomas Zander - University Hospital Cologne, Germany

Routine molecular testing of non-small cell lung cancers in community settings ( Dr Thomas Zander - University Hospital Cologne, Germany )

Increased progression-free survival in advanced lung cancer with afatinib

Dr James Yang - National Taiwan University Hospital Taipei, Taiwan

Increased progression-free survival in advanced lung cancer with afatinib ( Dr James Yang - National Taiwan University Hospital Taipei, Taiwan )

Bendamustine regimen more effective for lymphoma than standard CHOP

Dr Mathias Rummel - Universitaetsklinik, Giessen, Germany

Bendamustine regimen more effective for lymphoma than standard CHOP ( Dr Mathias Rummel - Universitaetsklinik, Giessen, Germany )

Problems in the structure of clinical trials

Prof Thomas Tursz – Institut Gustave Roussy, Paris, France

Problems in the structure of clinical trials ( Prof Thomas Tursz – Institut Gustave Roussy, Paris, France )

Prognostic biomarkers and next generation genomic sequencing

Prof Stefan Pfister – Cancer Research Centre, Heidelberg, Germany

Prognostic biomarkers and next generation genomic sequencing ( Prof Stefan Pfister – Cancer Research Centre, Heidelberg, Germany )

More from ecancer